Description
Pharmaceutical Research and Risk Europe 2011 will cover Key areas in the European R&D market Optimisation and Risk assessment.
Topics include: the potential for drug redevelopment and reformulation, Process development, optimization, risk assessment and new strategies that need to be implemented in order to develop R&D pipelines.
